JP2002522399A5 - - Google Patents

Download PDF

Info

Publication number
JP2002522399A5
JP2002522399A5 JP2000563311A JP2000563311A JP2002522399A5 JP 2002522399 A5 JP2002522399 A5 JP 2002522399A5 JP 2000563311 A JP2000563311 A JP 2000563311A JP 2000563311 A JP2000563311 A JP 2000563311A JP 2002522399 A5 JP2002522399 A5 JP 2002522399A5
Authority
JP
Japan
Prior art keywords
uricase
conjugate
peg
kda
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000563311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522399A (ja
JP5183836B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/017514 external-priority patent/WO2000007629A2/en
Publication of JP2002522399A publication Critical patent/JP2002522399A/ja
Publication of JP2002522399A5 publication Critical patent/JP2002522399A5/ja
Application granted granted Critical
Publication of JP5183836B2 publication Critical patent/JP5183836B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2000563311A 1998-08-06 1999-08-02 Ｐｅｇ−尿酸酸化酵素結合体およびその使用 Expired - Fee Related JP5183836B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13039298A 1998-08-06 1998-08-06
US09/130,392 1998-08-06
PCT/US1999/017514 WO2000007629A2 (en) 1998-08-06 1999-08-02 Peg-urate oxidase conjugates and use thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009173148A Division JP5290901B2 (ja) 1998-08-06 2009-07-24 Ｐｅｇ−尿酸酸化酵素結合体およびその使用
JP2012248770A Division JP5291235B2 (ja) 1998-08-06 2012-11-12 Ｐｅｇ−尿酸酸化酵素結合体およびその使用

Publications (3)

Publication Number Publication Date
JP2002522399A JP2002522399A (ja) 2002-07-23
JP2002522399A5 true JP2002522399A5 (enrdf_load_stackoverflow) 2008-05-08
JP5183836B2 JP5183836B2 (ja) 2013-04-17

Family

ID=22444494

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000563311A Expired - Fee Related JP5183836B2 (ja) 1998-08-06 1999-08-02 Ｐｅｇ−尿酸酸化酵素結合体およびその使用
JP2009173148A Expired - Fee Related JP5290901B2 (ja) 1998-08-06 2009-07-24 Ｐｅｇ−尿酸酸化酵素結合体およびその使用
JP2012248770A Expired - Fee Related JP5291235B2 (ja) 1998-08-06 2012-11-12 Ｐｅｇ−尿酸酸化酵素結合体およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009173148A Expired - Fee Related JP5290901B2 (ja) 1998-08-06 2009-07-24 Ｐｅｇ−尿酸酸化酵素結合体およびその使用
JP2012248770A Expired - Fee Related JP5291235B2 (ja) 1998-08-06 2012-11-12 Ｐｅｇ−尿酸酸化酵素結合体およびその使用

Country Status (13)

Country Link
EP (1) EP1100542B1 (enrdf_load_stackoverflow)
JP (3) JP5183836B2 (enrdf_load_stackoverflow)
KR (2) KR100488848B1 (enrdf_load_stackoverflow)
AU (1) AU770014B2 (enrdf_load_stackoverflow)
BR (2) BRPI9917760B8 (enrdf_load_stackoverflow)
CZ (1) CZ303751B6 (enrdf_load_stackoverflow)
HU (2) HU228916B1 (enrdf_load_stackoverflow)
IL (3) IL141220A0 (enrdf_load_stackoverflow)
NZ (1) NZ509595A (enrdf_load_stackoverflow)
PL (2) PL220873B1 (enrdf_load_stackoverflow)
RU (3) RU2246318C2 (enrdf_load_stackoverflow)
TW (1) TW570981B (enrdf_load_stackoverflow)
WO (1) WO2000007629A2 (enrdf_load_stackoverflow)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
JP2002524053A (ja) 1998-08-06 2002-08-06 デューク・ユニバーシティー 尿酸オキシダーゼ
IL141220A0 (en) * 1998-08-06 2002-03-10 Mountain View Pharmaceuticals Conjugates of peg-urate oxidase and use thereof
AU2006203252B8 (en) * 2000-02-10 2009-06-18 Duke University Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US7455855B2 (en) 2000-04-03 2008-11-25 Santen Pharmaceutical Co., Ltd. Delivering substance and drug delivery system using the same
WO2002000210A2 (en) * 2000-06-28 2002-01-03 Merck & Co., Inc. Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
WO2003002716A2 (en) 2001-06-28 2003-01-09 Mountain View Pharmaceuticals, Inc. Polymer stabilized proteinases
US6913915B2 (en) * 2001-08-02 2005-07-05 Phoenix Pharmacologics, Inc. PEG-modified uricase
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
BRPI0411172A (pt) 2003-05-12 2006-07-18 Affymax Inc peptìdeo, dìmero de peptìdeo, seu uso e composição farmacêutica
JP2007500218A (ja) 2003-05-12 2007-01-11 アフィーマックス・インコーポレイテッド ポリ（エチレングリコール）修飾ペプチド系化合物の新規スペーサー部分
CA2571292C (en) * 2004-06-30 2013-05-21 Nektar Therapeutics Al, Corporation Polymer-factor ix moiety conjugates
KR101304289B1 (ko) 2005-04-11 2013-09-12 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
LT3321359T (lt) 2005-04-11 2021-05-10 Horizon Pharma Rheumatology Llc Urato oksidazės variantinės formos ir jų panaudojimas
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
JP2008545627A (ja) 2005-05-09 2008-12-18 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド 腎結石症を治療する方法
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
JP4890132B2 (ja) * 2006-07-20 2012-03-07 東洋紡績株式会社 ウリカーゼの比活性を向上させる方法、および比活性の向上した改変型ウリカーゼ
RU2382048C1 (ru) * 2008-12-25 2010-02-20 Общество С Ограниченной Ответственностью "Фармапарк" Лекарственное средство на основе модифицированного интерферона альфа с пролонгированным терапевтическим действием
CZ2011827A3 (cs) 2009-06-25 2012-09-26 Savient Pharmaceuticals, Inc. Zpusoby a sady pro predpovídání rizika reakce na infuzi a ztráty odezvy zpusobené protilátkami, monitorováním kyseliny mocové v séru behem lécby pegylovanou urikázou
BR112013005792A8 (pt) 2010-09-10 2018-05-08 Takeda Pharmaceuticals Usa Inc métodos para o tratamento concomitante de teofilina e febuxostat
CN102634492B (zh) 2011-02-14 2015-06-10 重庆富进生物医药有限公司 聚乙二醇化犬源尿酸氧化酶类似物及其制备方法和应用
WO2013151638A1 (en) 2012-04-06 2013-10-10 Indus Pharmaceuticals, Inc. Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment
MY190411A (en) * 2015-05-15 2022-04-21 Medimmune Llc Improved uricase sequences and methods of treatment
CN105412942B (zh) * 2015-12-23 2019-02-26 沈阳三生制药有限责任公司 聚乙二醇化的重组产朊假丝酵母尿酸氧化酶冻干注射剂
US11426451B2 (en) 2017-03-11 2022-08-30 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant
CN112980808B (zh) * 2019-12-12 2024-10-29 深圳迈瑞生物医疗电子股份有限公司 尿酸酶、及其制备方法和用途
KR20230110281A (ko) 2020-11-03 2023-07-21 프로탈릭스 리미티드 변형된 유리카제(uricase) 및 이의 용도
CN114438047B (zh) * 2020-11-05 2024-11-22 重庆派金生物科技有限公司 制备聚乙二醇修饰的尿酸氧化酶的方法
CN114438048B (zh) * 2020-11-05 2024-10-22 重庆派金生物科技有限公司 尿酸氧化酶制剂及其应用
US20240060063A1 (en) 2021-02-10 2024-02-22 Oriental Yeast Co., Ltd. Uricase activator and uric acid measurement reagent
CN114181917B (zh) * 2022-02-14 2022-06-03 潍坊华卓生物科技有限公司 一种改造尿酸酶、基因序列、制备方法及应用
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6301M (enrdf_load_stackoverflow) * 1967-03-29 1968-09-09
US3616231A (en) * 1968-11-14 1971-10-26 Boehringer Mannheim Gmbh Process for the production of uricase
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6031472B2 (ja) * 1978-12-14 1985-07-22 協和醗酵工業株式会社 酸性ウリカ−ゼ
JPS55135590A (en) * 1979-04-05 1980-10-22 Mihama Hisaharu Modified asparaginase and uricase and their preparation
JPS57192435A (en) * 1981-05-20 1982-11-26 Toyobo Co Ltd Modified polypeptide
JPS6255079A (ja) * 1986-04-23 1987-03-10 Mihama Hisaharu 修飾ウリカ−ゼ
NZ234453A (en) * 1989-07-13 1993-01-27 Sanofi Sa Recombinant dna encoding urate oxidase, and vector, host, protein and pharmaceutical compositions associated therewith
IL141220A0 (en) * 1998-08-06 2002-03-10 Mountain View Pharmaceuticals Conjugates of peg-urate oxidase and use thereof
JP2002524053A (ja) * 1998-08-06 2002-08-06 デューク・ユニバーシティー 尿酸オキシダーゼ
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates

Similar Documents

Publication Publication Date Title
JP2002522399A5 (enrdf_load_stackoverflow)
CA2338665A1 (en) Peg-urate oxidase conjugates and use thereof
RU2001103144A (ru) Конъюгаты peg-уратоксидазы и их использование
US11781119B2 (en) Variant forms of urate oxidase and use thereof
CN100491532C (zh) 用于制备非免疫原性聚合物性缀合物的无聚集体尿酸氧化酶
RU2002120486A (ru) Свободная от агрегатов уратоксидаза для приготовления неиммуногенных полимерных конъюгатов
JP2003521937A5 (enrdf_load_stackoverflow)
RU2006107111A (ru) Коньюгаты peg-уратоксидазы их использование, способ изолирования тетрамерной формы уриказы
AU2001249975A1 (en) Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
Powers-Greenwood et al. Separation of protein X from the dihydrolipoyl transacetylase component of the mammalian pyruvate dehydrogenase complex and function of protein X
Zalipsky et al. Thiolytically cleavable dithiobenzyl urethane-linked polymer–protein conjugates as macromolecular prodrugs: reversible PEGylation of proteins
RU2008132767A (ru) Конъюгаты уратоксидазы с сохраненной уриколитической активностью и увеличенным периодом полураспада, фармацевтическая композиция для снижения уровней мочевой кислоты и способ выделения тетрамерной формы уратоксидазы из раствора тетрамерной формы и агрегатов уратоксидазы
HK1056742B (en) Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
PL203492B1 (pl) Koniugat urykazy i jego zastosowanie oraz kompozycja farmaceutyczna